Bio-Pharm

Huons is set to expand its biopharmaceutical R&D and contract development and manufacturing organization (CDMO)…

The Korean Dementia Association has addressed safety concerns related to the upcoming domestic release of the…

Samsung Bioepis has surpassed its total annual revenue from last year within the first three quarters of 2023. The…

Boryung is getting closer to achieving 1 trillion KRW ($740 million) in annual sales for the first time, supported by…

Yuhan Corporation’s third-quarter operating profit has skyrocketed, primarily due to license revenue from its…

Following Samsung Biologics’ announcement of its third-quarter results, several securities firms have raised their…

SK bioscience announced that its quadrivalent cell-culture influenza vaccine, SkyCellflu Quadrivalent Pre-filled…

Samsung Biologics has made headlines again. On the 22nd, the company announced that it had signed a massive Contract…

It's been two and a half years since OCI became the largest shareholder of Bukwang Pharmaceutical, yet instead of…

Contrast-enhanced mammography (CEM) is gaining attention as a crucial method in the fight against breast cancer, the…

DongKook Pharmaceutical strengthens its cosmetics business by acquiring ReBom Cosmetics. On the 16th, DongKook…

STGen Bio announced on the 14th that its Songdo Bio Plant has received current Good Manufacturing Practice (cGMP)…

Hugel has won the final ruling in the botulinum toxin-related lawsuit it faced against Medytox in the United States…

Liga-Chem Biosciences announced on the 10th that it had signed two licensing agreements with Ono Pharmaceutical, a…

Orum Therapeutics, a biotechnology company preparing for its KOSDAQ listing, announced its goal to achieve sales of KRW…

There is an evaluation that Samsung Biologics' stock could rise in the short term if the U.S. Biosecurity Law is passed.…

Celltrion has officially entered the ASEAN market by establishing a local subsidiary in Vietnam. Following the company's…

Celltrion announced on the 27th that it has launched a media campaign in the U.S. for "Zymfentra," the world’s only…

HK inno.N's novel drug for gastroesophageal reflux disease (GERD), K-CAB, has received marketing approval in Malaysia.…

Samsung Biologics announced on the 25th that it has introduced two new Contract Development Organization (CDO) platforms…